Tirosint 88 MCG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FN4QW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,351
Award facts
- Contract value 100% obligated
- $1,350.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,350.78 to AmerisourceBergen Drug Corp for Tirosint 88 micrograms capsules (30-count supply) on September 25, 2025, with completion targeted for September 26, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate office location. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply medications and medical supplies to military healthcare programs worldwide.
Tirosint, a brand-name levothyroxine product, represents the type of specialty pharmaceutical commodity frequently procured through the DLA Medical Supply Chain to support military healthcare systems. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role as a pharmaceutical prime vendor for Defense Health Agency, U.S. Coast Guard, and other government healthcare organizations. The company's capability to deliver both high-volume and specialized medication orders through competitive procurement processes reflects its significance within the federal medical logistics ecosystem and the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB25FN4QW?
SPE2DB25FN4QW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FN4QW worth?
The government has obligated $1,351 on SPE2DB25FN4QW.
Is contract SPE2DB25FN4QW an order under another contract?
Yes. SPE2DB25FN4QW is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN4QW competed?
The extent of competition for SPE2DB25FN4QW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award